Reliable Biopharmaceutical Corporation (RBC) Announced Today the Launch of GMP Urea, USP
Reliable Biopharmaceutical Corporation (RBC) announced today the launch of Urea, USP. This product is manufactured under GMP and is designed to meet the growing quality demands of the Biopharmaceutical industry.
St. Louis, MO (PRWEB) July 18, 2013
Urea is used in many critical processes by the biopharmaceutical industry. As regulations surrounding supply chain and excipient quality become more stringent, there is a need for high quality GMP excipient manufacturers. Reliable GMP Urea, USP is manufactured following stringent GMP guidelines in a newly constructed and qualified manufacturing suite at their US facility. "In this industry, it is not always clear that USP means GMP. When you buy from Reliable, you can be assured that when we say USP, a GMP process using the highest quality conditions is utilized," said David Feldker, CEO and President of Reliable Biopharmaceutical Corporation.
RBC has several other GMP excipients being launched over the next several weeks and months. RBC continues to offer non-GMP high purity grades of Urea for other applications.
About Reliable Biopharmaceutical Corporation
Founded in 1968, RBC is an integrated developer and manufacturer of Active Pharmaceutical Ingredients (APIs) and High Purity Ingredients (HPIs) for pharmaceuticals and biologics. RBC has established a strong position as a leading developer and manufacturer of complex generic injectable APIs. The company has a number of DMFs that have been accepted by Regulatory Agencies and has more in various stages of development. RBC's APIs are in leading generic injectable drugs that treat cancer, heart disease, hypertension, anxiety and other serious and life threatening illnesses. RBC HPIs are critical processing aids for many of the world's leading pharmaceutical and biotechnology companies.
For the original version on PRWeb visit: http://www.prweb.com/releases/2013/7/prweb10935151.htm